MedTrace Logo

Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis

NCT04148053 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2019-11-01

No results posted yet for this study

Summary

Diagnosis of active and latent pulmonary tuberculosis, as well as extrapulmonary tuberculosis, is still a major challenge of TB control in China. This observational study aims to evaluate TB-antigen responsive T cell markers in the diagnosis of tuberculosis and extrapulmonary tuberculosis and try to find new prompt and cost-effective laboratory tests for active TB screening.

Conditions

  • Tuberculosis Infection

Interventions

DIAGNOSTIC_TEST

TB-antigen responsive T cell markers

A blood test including a series of T cell markers which are responsive to TB antigens

Sponsors & Collaborators

  • Tongji University

    lead OTHER

Eligibility

Min Age
7 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2019-12-31
Completion
2020-03-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04148053 on ClinicalTrials.gov